Home
About
AI
Biotech
Energy
Research
Robotics
Space
Contact us
Search
8
C
Glasgow
Monday, March 30, 2026
Home
About
AI
Biotech
Energy
Research
Robotics
Space
Contact us
Search
Home
About
AI
Biotech
Energy
Research
Robotics
Space
Contact us
Search
Home
Tags
Johnson & Johnson
Tag:
Johnson & Johnson
biotech
CRS programme to feature Poolbeg Pharma trial
Jim Cornall
-
December 11, 2025
biotech
“Turning point in how we treat EGFR-mutated lung cancer”
Jim Cornall
-
September 10, 2025
biotech
Johnson & Johnson aiming to revolutionise plaque psoriasis treatment
Jim Cornall
-
July 24, 2025
biotech
Johnson & Johnson receives Priority Review for high-risk non-muscle invasive bladder cancer treatment
Jim Cornall
-
July 22, 2025
- Advertisement -
Latest Articles
biotech
Lyme disease vaccine shows strong efficacy in phase 3 trial
biotech
FDA approves pill for plaque psoriasis
biotech
Crossbow Therapeutics raises $77m to treat cancer
biotech
Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space
biotech
Excalipoint Therapeutics launches with $68.7m to develop T-Cell engager therapies
Load more